* Axonics Inc AXNX.OQ AXNX.O is expected to show a rise
in
quarterly revenue when it reports results on April 29
(estimated) for the period ending March 31 2024
* The Irvine California-based company is expected to report
a
27.3% increase in revenue to $89.94 million from $70.65 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Axonics Inc is for a
loss of 8
cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 12
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Axonics Inc
is
$71.00, above its last closing price of $66.54.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.09 0.06 0.13 Beat 123.4
Sep. 30 2023 -0.05 -0.05 0.08 Beat 245.5
Jun. 30 2023 -0.10 -0.11 0.16 Beat 240.8
Mar. 31 2023 -0.28 -0.29 -0.19 Beat 33.9
Dec. -0.27 -0.24 0.01 Beat 104.1
31 2022
Sep. 30 2022 -0.48 -0.48 -0.34 Beat 28.5
Jun. 30 2022 -0.54 -0.54 -0.47 Beat 13.4
Mar. 31 2022 -0.65 -0.63 -0.50 Beat 21
This summary was machine generated April 26 at 11:50 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)